OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Turning Microbial AhR Agonists into Therapeutic Agents via Drug Delivery Systems
Matteo Puccetti, Marilena Pariano, Paulina Wojtylo, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 506-506
Open Access | Times Cited: 7
Matteo Puccetti, Marilena Pariano, Paulina Wojtylo, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 506-506
Open Access | Times Cited: 7
Showing 7 citing articles:
Host–microbe serotonin metabolism
Emilia Nunzi, Marilena Pariano, Claudio Costantini, et al.
Trends in Endocrinology and Metabolism (2024)
Open Access | Times Cited: 8
Emilia Nunzi, Marilena Pariano, Claudio Costantini, et al.
Trends in Endocrinology and Metabolism (2024)
Open Access | Times Cited: 8
Indole‐3‐Lactic Acid Inhibits Doxorubicin‐Induced Ferroptosis Through Activating Aryl Hydrocarbon Receptor/Nrf2 Signalling Pathway
Jiangfang Lian, Hangyuan Guo, Zuoquan Zhong, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access | Times Cited: 1
Jiangfang Lian, Hangyuan Guo, Zuoquan Zhong, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access | Times Cited: 1
Harnessing and delivering microbial metabolites as therapeutics via advanced pharmaceutical approaches
Lindsey Williams, Shijie Cao
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108605-108605
Closed Access | Times Cited: 5
Lindsey Williams, Shijie Cao
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108605-108605
Closed Access | Times Cited: 5
Challenges and limitations in using bacterial metabolites as immunomodulators
Chinnashanmugam Saravanan, N. S. Gopinath, Raja Ganesan, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Chinnashanmugam Saravanan, N. S. Gopinath, Raja Ganesan, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Harnessing inter-kingdom metabolic disparities at the human-fungal interface for novel therapeutic approaches
Claudio Costantini, Marilena Pariano, Matteo Puccetti, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 2
Claudio Costantini, Marilena Pariano, Matteo Puccetti, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 2
Bacteria and fungi of the lung: allies or enemies?
Enrico Garaci, Marilena Pariano, Emilia Nunzi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Enrico Garaci, Marilena Pariano, Emilia Nunzi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Human and gut microbiota synergy in a metabolically active superorganism: a cardiovascular perspective
Matteo Antonio Russo, Matteo Puccetti, Claudio Costantini, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access
Matteo Antonio Russo, Matteo Puccetti, Claudio Costantini, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access
